News

ALX Oncology's Promising Advances at Upcoming Symposium

ALX Oncology's Promising Advances at Upcoming Symposium

Exciting Developments from ALX Oncology

ALX Oncology Holdings Inc., a pioneering clinical-stage biotechnology company, has some promising news to share. Focused on revolutionizing cancer treatment through immune system enhancement, the company has announced significant findings from its Phase 1b/2 trial. This study evaluates evorpacept, ALX’s lead therapeutic candidate, in combination with zanidatamab.

Details of the Clinical Trial

The trial targets patients with HER2-positive and HER2-low metastatic breast cancer. This dual-part, open-label multicenter study aims to assess the effectiveness of evorpacept paired with zanidatamab as a novel treatment option. Acceptance for spotlight presentation at the San Antonio Breast Cancer Symposium (SABCS) confirms the relevance and importance of the results involved in this clinical exploration.

Presentation Highlights

The captivating insights from this study will be shared in a poster spotlight presentation at SABCS, occurring in December. Notable details for this presentation include its title: Zanidatamab in combination with evorpacept in HER2-positive and HER2-low metastatic breast cancer: Results from a phase 1b/2 study. Alberto J. Montero, M.D., will serve as the presenter, delivering insights into how these therapies may reshape treatment landscapes.

ALX Oncology's Mission and Vision

As a company, ALX Oncology is committed to building innovative therapies aimed at harnessing the body’s immune response against cancer. Their focus on evorpacept exemplifies this mission, showing potential not just as an isolated therapy but as a foundational pillar in immuno-oncology.

Ongoing Trials and Future Directions

Currently, evorpacept is being examined in various clinical trials, addressing multiple types of cancer. This ongoing research signifies ALX Oncology’s commitment toward providing safer and more effective treatment alternatives for cancer patients. With future evaluations anticipated, the landscape of cancer treatment may soon undergo dramatic shifts thanks to these efforts.

Company Commitment to Patients and Community

ALX Oncology does not merely focus on novel therapies; they prioritize patient engagement and community support. As they continue to navigate the complexities of cancer treatment, their dedication to transparency and patient-centric approaches is invaluable.

Contact Information for Inquiries

For those interested in more details about ALX Oncology's developments, the company’s communications team is ready to assist. Caitlyn Doherty can be reached for corporate communications inquiries, while investor relations inquiries can be directed to Malini Chatterjee. The media contact for any press-related queries is Audra Friis.

Frequently Asked Questions

What is the focus of the Phase 1b/2 trial?

The trial evaluates evorpacept in combination with zanidatamab for HER2-positive and HER2-low metastatic breast cancer.

Who is presenting the results of the study?

Alberto J. Montero, M.D., will present the results during the spotlight session at the SABCS.

When and where will the presentation take place?

The presentation will occur on Thursday, December 12, at the Henry B. Gonzalez Convention Center in San Antonio.

What is the potential impact of evorpacept?

Evorpacept aims to provide a new cornerstone therapy in immuno-oncology, enhancing the immune system's ability to fight cancer.

How can I learn more about ALX Oncology's initiatives?

Interested individuals can visit the company's official website or reach out directly to their communication or investor relations teams.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 5

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 11

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Supply Maverick Simplifies Global Shipping Processes

Updated Category News Views 5

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 3

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 5

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
QuickFi Nabs Top Finovate Award for Fourth Time

Updated Category News Views 5

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Continue Reading
High-Grade Copper Spurs Optimism for PolarX in Alaska

Updated Category News Views 4

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 8

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 6

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading

Top 5 Most Recently Viewed Articles

SOWG Stock Faces Challenges While Showing Revenue Resilience

Updated Category News Views 99

Black Ridge Oil & Gas Stock Performance Review In the current volatile market landscape, Black Ridge Oil & Gas (SOWG) has experienced significant challenges, notably hitting a 52-week low at $3.46 per share. This decline is a result of broader market pressures affecting the energy sector, which has seen share prices across various companies reeling under economic...

Continue Reading
Nokia and Samsung Form Strategic Partnership for Patents

Updated Category News Views 231

Nokia and Samsung Strike Landmark Patent License Agreement Nokia, a prominent player in telecommunications, has recently made headlines with the announcement of a significant multi-year patent license agreement with tech giant Samsung. This collaboration is focused on utilizing Nokia's innovative video technologies in Samsung's television products. Details of the...

Continue Reading
Astec Enhances IVF Technology with Life Whisperer Acquisition

Updated Category News Views 81

Astec's Strategic Acquisition of Life Whisperer Astec, a renowned global manufacturer specializing in medical equipment for assisted reproduction, has recently made a significant advance in the fertility sector by acquiring Presagen's Life Whisperer. This cutting-edge technology serves as a non-invasive, rapid assessment tool for embryos and eggs (oocytes), aiming to...

Continue Reading
What $1000 Investment in Analog Devices Could Yield Today

Updated Category News Views 126

The Growth Journey of Analog Devices Investing in stocks can be an exciting journey, particularly when analyzing companies like Analog Devices (NASDAQ: ADI). Over the past 15 years, this company has displayed remarkable performance, outperforming the market by 6.98% annually, resulting in an impressive average annual return of 19.31%. As of now, Analog Devices boasts a...

Continue Reading
Xcel Energy Advances Towards a Sustainable Clean Energy Future

Updated Category News Views 344

Xcel Energy's Commitment to Clean Energy Initiatives Xcel Energy is making significant progress in its efforts to cut emissions and promote clean energy. As the country increasingly turns towards sustainability, Xcel Energy stands out by launching various initiatives designed to foster a cleaner environment. Major Milestones in Carbon Emission Reduction Over the years,...

Continue Reading